Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • headache

    Tag: headache

    You Searched For "headache"
    Pfizer recalls 2 lots of migraine drug RELPAX over possible microbial contamination

    Pfizer recalls 2 lots of migraine drug RELPAX over possible microbial contamination

    Farhat Nasim17 Aug 2019 9:14 AM IST
    Lots of Pfizer Inc's Relpax were distributed nationwide to wholesalers, retailers, hospitals and healthcare providers in the 50 states and Puerto Rico...
    DOP junks Geltec plea against NPPA decision on retail price of Ibuprofen Soft Gelatin Capsules

    DOP junks Geltec plea against NPPA decision on retail price of Ibuprofen Soft Gelatin Capsules

    Farhat Nasim28 July 2019 11:30 AM IST
    New Delhi: Through a recent decision, the Department of Pharmaceuticals (DOP) has rejected the review application filed by Geltec Private Limited...
    Dr Reddys to sell Tosymra, Zembrace to Upsher-Smith Labs for Rs 765 crore approx

    Dr Reddys to sell Tosymra, Zembrace to Upsher-Smith Labs for Rs 765 crore approx

    Farhat Nasim15 Jun 2019 10:00 AM IST
    Dr Reddy's (Dr Reddys) Labs said Tosymra and Zembrace were designed and developed with the goal of addressing unmet needs of large but discrete...
    Eli Lilly to present new data on Emgality, Lasmiditan at AAN annual meeting

    Eli Lilly to present new data on Emgality, Lasmiditan at AAN annual meeting

    Farhat Nasim5 May 2019 10:00 AM IST
    Emgality is also currently under Priority Review by the FDA as an investigational drug for the preventive treatment of episodic cluster headache in...
    USFDA accepts Allergan license applications to expand Botox label

    USFDA accepts Allergan license applications to expand Botox label

    Farhat Nasim11 March 2019 9:30 AM IST
    "The FDA's acceptance of Allergan's supplemental biologics license applications is a monumental milestone on our journey to bring new treatment...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok